TOPGEN

About:

TOPGEN provides tumor-oriented precision medical testing, cellular immunotherapy, and other services.

Website: http://www.topgen.com.cn/

Top Investors: CAS Investment Management, Step Venture Capital, Guoke Zhengdao Investment, Zhujijingkaichuangrong Touzi, Zhuji Jingkai Chuangyou Guquan Jijin

Description:

TOPGEN is committed to tumor precision medical products and engages in precision medicine. Continuous industry research and development, as well as the construction of an industry ecology, will protect human health. It adheres to international norms, standards, and industry guidelines, as well as introduces and develops international advanced technologies and testing methods. It serves large tertiary hospitals, specialized hospitals, general hospitals, research institutions, and pharmaceutical companies in China.

Total Funding Amount:

252M CNY

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2012-01-01

Contact Email:

topgen(AT)topgen.com.cn

Founders:

Shen Weiqiang

Number of Employees:

251-500

Last Funding Date:

2022-06-02

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai